Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Feb;36(2):191-200.
doi: 10.1165/rcmb.2006-0021TR. Epub 2006 Sep 15.

Beryllium-induced TNF-alpha production is transcription-dependent in chronic beryllium disease

Affiliations

Beryllium-induced TNF-alpha production is transcription-dependent in chronic beryllium disease

Richard T Sawyer et al. Am J Respir Cell Mol Biol. 2007 Feb.

Abstract

Beryllium (Be)-antigen presentation to Be-specific CD4(+) T cells from the lungs of patients with chronic beryllium disease (CBD) results in T cell proliferation and TNF-alpha secretion. We tested the hypothesis that Be-induced, CBD bronchoalveolar lavage (BAL) T cell, transcription-dependent, TNF-alpha secretion was accompanied by specific transcription factor upregulation. After 6 h of Be stimulation, CBD BAL cells produced a median of 883 pg/ml TNF-alpha (range, 608-1,275 pg/ml) versus 198 pg/ml (range, 116-245 pg/ml) by unstimulated cells. After 12 h CBD BAL cells produced a median of 2,963 pg/ml (range, 99-9,424 pg/ml) TNF-alpha versus 55 pg/ml (range, 0-454) by unstimulated cells. Using real-time RT-PCR, Be-stimulated TNF-alpha production at 6 h was preceded by a 5-fold increase in TNF-alpha pre-mRNA copy number:beta-actin copy number (Be median ratio 0.21; unstimulated median ratio 0.04). The median ratio of mature TNF-alpha mRNA:beta-actin mRNA was upregulated 1.4-fold (Be median ratio 0.17; unstimulated median ratio 0.12). Be exposure in the presence of the transcription inhibitor pentoxifylline (PTX) decreased CBD BAL cell TNF-alpha pre-mRNA levels > 60%, whereas treatment with the mRNA splicing inhibitor 2-aminopurine (2AP) decreased levels 40% relative to Be exposure alone. PTX treatment decreased mature TNF-alpha mRNA levels 50% while 2AP decreased levels > 80%, relative to Be exposure alone. Beryllium exposure specifically upregulated transcription factors AP-1 and NF-kappaB. The data suggest that Be exposure induces transcription-dependent TNF-alpha production, potentially due to upregulation of specific transcription factors.

PubMed Disclaimer

Figures

<b>Figure 1.</b>
Figure 1.
(a) A representative example of intracellular TNF-α expression by CD4+ BAL T cells from a patient with CBD after short-term culture with medium alone, 10 μM BeSO4, or 10 ng/ml SEB. The percentage of CD4+ CBD BAL T cells expressing intracellular TNF-α is shown in the upper right quadrant of each density plot. (b) The percentage (%) of CD4+ BAL T cells expressing intracellular TNF-α in response to either medium alone, 10 μM BeSO4, or SEB is shown. The bar indicates the median value for the four subjects with CBD tested.
<b>Figure 2.</b>
Figure 2.
The kinetics of TNF-α mRNA upregulation in Be-stimulated CBD BAL cells (n = 4). (a) The median ratio of TNF-α pre-mRNA copy number to β-actin mature mRNA copy number at 0, 0.5, and 1 h in unstimulated (open bars) and Be-stimulated (filled bars; 100 μM BeSO4) CBD BAL cells. (b) The median ratio of TNF-α mature-mRNA copy number to β-actin mature mRNA copy number at 0, 0.5, and 1 h in unstimulated (open bars) and Be-stimulated (filled bars; 100 μM BeSO4) CBD BAL cells. *P < 0.05, Wilcoxon matched pairs.
<b>Figure 3.</b>
Figure 3.
Transcription-mediated TNF-α pre-mRNA copy number and mature mRNA copy number:β-actin mature mRNA copy number in CBD BAL cells (n = 4) after 6 h of Be stimulation (100 μM BeSO4). (a) The median ratio of TNF-α pre-mRNA to β-actin after exposure to 100 μM BeSO4 alone (solid bars) versus Be + PTX (open bars) or Be + 2AP (striped bars). (b) The median ratio of TNF-α mature mRNA to β-actin after exposure to 100 μM BeSO4 alone (solid bars) versus Be + PTX (open bars) or Be + 2AP (striped bars). (c) The median ratio of TNF-α pre-mRNA to β-actin after culture in medium alone (solid bars) or medium alone + PTX (open bars) or + 2AP (striped bars). (d) The median levels of TNF-α mature mRNA to β-actin after culture in medium alone (solid bars) or medium alone + PTX (open bars) or + 2AP (striped bars). (e) The median levels of TNF-α pre-mRNA to β-actin after exposure to 1 μg/ml LPS alone (solid bars) versus LPS + PTX (open bars) or LPS + 2AP (striped bars). (f) The median levels of TNF-α mature mRNA to β-actin after exposure to 1 μg/ml LPS alone (solid bars) versus LPS + PTX (open bars) or LPS + 2AP (striped bars).
<b>Figure 3.</b>
Figure 3.
Transcription-mediated TNF-α pre-mRNA copy number and mature mRNA copy number:β-actin mature mRNA copy number in CBD BAL cells (n = 4) after 6 h of Be stimulation (100 μM BeSO4). (a) The median ratio of TNF-α pre-mRNA to β-actin after exposure to 100 μM BeSO4 alone (solid bars) versus Be + PTX (open bars) or Be + 2AP (striped bars). (b) The median ratio of TNF-α mature mRNA to β-actin after exposure to 100 μM BeSO4 alone (solid bars) versus Be + PTX (open bars) or Be + 2AP (striped bars). (c) The median ratio of TNF-α pre-mRNA to β-actin after culture in medium alone (solid bars) or medium alone + PTX (open bars) or + 2AP (striped bars). (d) The median levels of TNF-α mature mRNA to β-actin after culture in medium alone (solid bars) or medium alone + PTX (open bars) or + 2AP (striped bars). (e) The median levels of TNF-α pre-mRNA to β-actin after exposure to 1 μg/ml LPS alone (solid bars) versus LPS + PTX (open bars) or LPS + 2AP (striped bars). (f) The median levels of TNF-α mature mRNA to β-actin after exposure to 1 μg/ml LPS alone (solid bars) versus LPS + PTX (open bars) or LPS + 2AP (striped bars).
<b>Figure 3.</b>
Figure 3.
Transcription-mediated TNF-α pre-mRNA copy number and mature mRNA copy number:β-actin mature mRNA copy number in CBD BAL cells (n = 4) after 6 h of Be stimulation (100 μM BeSO4). (a) The median ratio of TNF-α pre-mRNA to β-actin after exposure to 100 μM BeSO4 alone (solid bars) versus Be + PTX (open bars) or Be + 2AP (striped bars). (b) The median ratio of TNF-α mature mRNA to β-actin after exposure to 100 μM BeSO4 alone (solid bars) versus Be + PTX (open bars) or Be + 2AP (striped bars). (c) The median ratio of TNF-α pre-mRNA to β-actin after culture in medium alone (solid bars) or medium alone + PTX (open bars) or + 2AP (striped bars). (d) The median levels of TNF-α mature mRNA to β-actin after culture in medium alone (solid bars) or medium alone + PTX (open bars) or + 2AP (striped bars). (e) The median levels of TNF-α pre-mRNA to β-actin after exposure to 1 μg/ml LPS alone (solid bars) versus LPS + PTX (open bars) or LPS + 2AP (striped bars). (f) The median levels of TNF-α mature mRNA to β-actin after exposure to 1 μg/ml LPS alone (solid bars) versus LPS + PTX (open bars) or LPS + 2AP (striped bars).
<b>Figure 4.</b>
Figure 4.
The levels of transcription factors NF-κB and AP-1 as determined by EMSA, in the nuclei of isolated CBD BAL cells from two subjects, that were unstimulated (−) or exposed to 100 μM BeSO4 (+). Constitutive levels of nuclear transcription factors were determined for NF-κB and AP-1 by EMSA in unstimulated, isolated CBD BAL macrophages (MO), and isolated CBD BAL T cells (T cell) at 0 time and are compared with the changes in transcription factor levels after 24 h in unstimulated isolated T cells (−) or isolated T cells exposed to 100 μM BeSO4 (+). Cold oligonucleotide competition (CC) controls (absence of a band), and EMSA antibody supershift (SS) assay controls (arrows on right) for isolated T cells after 24 h of exposure to 100 μM BeSO4 (+) indicated the specificity of the transcription factor bands.

Similar articles

Cited by

References

    1. Sawyer RT, Maier LA, Kittle LA, Newman LS. Chronic beryllium disease: A model interaction between innate and acquired immunity. Int Immunopharmacol 2002;2:249–261. - PubMed
    1. Fontenot AP, Canavera SJ, Gaharavi L, Newman LS, Kotzin BL. Target organ localization of memory CD4+ T cells in patients with chronic beryllium disease. J Clin Invest 2002;110:1473–1482. - PMC - PubMed
    1. Richeldi L, Sorrentino R, Saltini C. HLA-DPB1 glutamate 69: a genetic marker of beryllium disease. Science 1999;262:242–244. - PubMed
    1. Saltini C, Winestock K, Kirby M, Pinkston P, Crystal RG. Maintenance of alveolitis in patients with chronic beryllium disease by beryllium-specific helper T cells. N Engl J Med 1989;320:1103–1109. - PubMed
    1. Mroz MM, Kreiss K, Lezotte DC, Campbell PA, Newman LS. Re-examination of the blood lymphocyte transformation test in the diagnosis of chronic beryllium disease. J Allergy Clin Immunol 1991;88:54–60. - PubMed

Publication types

MeSH terms